Overview
Masahiko Hayashida practices in Tenri, Japan. Hayashida is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Their top areas of expertise are Large-Cell Immunoblastic Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Angioimmunoblastic T-cell Lymphoma.
Their clinical research consists of co-authoring 22 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 2 articles in the study of Chronic B-Cell Leukemia (CBCL).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Large-Cell Immunoblastic Lymphoma
- Experienced
- Angioimmunoblastic T-cell LymphomaHayashida isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaHayashida isExperienced. Learn about B-Cell Lymphoma.
- Burkitt LymphomaHayashida isExperienced. Learn about Burkitt Lymphoma.
- Chronic B-Cell Leukemia (CBCL)Hayashida isExperienced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Hayashida isExperienced. Learn about Chronic Lymphocytic Leukemia (CLL).
- Diffuse Large B-Cell Lymphoma (DLBCL)Hayashida isExperienced. Learn about Diffuse Large B-Cell Lymphoma (DLBCL).